PCH1
MCID: PNT010
MIFTS: 40

Pontocerebellar Hypoplasia Type 1 (PCH1)

Categories: Eye diseases, Fetal diseases, Genetic diseases, Mental diseases, Metabolic diseases, Muscle diseases, Neuronal diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Pontocerebellar Hypoplasia Type 1

MalaCards integrated aliases for Pontocerebellar Hypoplasia Type 1:

Name: Pontocerebellar Hypoplasia Type 1 20 58 29 6 71
Pontocerebellar Hypoplasia with Infantile Spinal Muscular Atrophy 20
Pontocerebellar Hypoplasia with Anterior Horn Cell Disease 20
Hypoplasia, Pontocerebellar, Type 1 39
Norman Disease 58
Pch1 58

Characteristics:

Orphanet epidemiological data:

58
pontocerebellar hypoplasia type 1
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: early childhood,infantile;

Classifications:

Orphanet: 58  
Rare neurological diseases
Developmental anomalies during embryogenesis


External Ids:

MESH via Orphanet 45 C548069
ICD10 via Orphanet 33 Q04.3
UMLS via Orphanet 72 C1843504
Orphanet 58 ORPHA2254
UMLS 71 C1843504

Summaries for Pontocerebellar Hypoplasia Type 1

GARD : 20 Pontocerebellar hypoplasia type 1 (PCH1) is a genetic disease that affects the development of the brain. Babies and children with this disease have an unusually small and underdeveloped cerebellum, which is the part of the brain that coordinates movement. A region of the brain called the pons also fails to develop properly. The pons, which is located at the base of the brain in an area called the brainstem, sends signals between the cerebellum and the rest of the brain. Individuals with PCH1 also experience a degeneration of the anterior horn cells, which are responsible for helping the spinal cord send signals to the muscles. Problems with the anterior horn cells cause severe muscle weakness. PCH1 is caused by mutations to EXOSC3, TSEN54, RARS2, and VRK1. The disease is inherited in an autosomal recessive manner. Diagnosis of PCH1 is based on brain imaging and tests to rule out other causes of problems with brain development. Treatment for PCH1 is aimed at relieving the symptoms of the disease. Most children with PCH1 pass away in infancy or early childhood.

MalaCards based summary : Pontocerebellar Hypoplasia Type 1, also known as pontocerebellar hypoplasia with infantile spinal muscular atrophy, is related to pontocerebellar hypoplasia, type 1a and pontocerebellar hypoplasia, type 5, and has symptoms including ataxia, muscle weakness and muscular fasciculation. An important gene associated with Pontocerebellar Hypoplasia Type 1 is VRK1 (VRK Serine/Threonine Kinase 1), and among its related pathways/superpathways are Gene Expression and Unfolded Protein Response (UPR). Affiliated tissues include brain, cerebellum and pons.

Related Diseases for Pontocerebellar Hypoplasia Type 1

Diseases in the Pontocerebellar Hypoplasia family:

Pontocerebellar Hypoplasia, Type 4 Pontocerebellar Hypoplasia, Type 2a
Pontocerebellar Hypoplasia, Type 1a Pontocerebellar Hypoplasia, Type 3
Pontocerebellar Hypoplasia, Type 5 Pontocerebellar Hypoplasia, Type 6
Pontocerebellar Hypoplasia, Type 2b Pontocerebellar Hypoplasia, Type 2c
Pontocerebellar Hypoplasia, Type 2d Pontocerebellar Hypoplasia, Type 1b
Pontocerebellar Hypoplasia, Type 8 Pontocerebellar Hypoplasia, Type 7
Pontocerebellar Hypoplasia, Type 10 Pontocerebellar Hypoplasia, Type 9
Pontocerebellar Hypoplasia, Type 2e Pontocerebellar Hypoplasia, Type 1c
Pontocerebellar Hypoplasia, Type 2f Pontocerebellar Hypoplasia, Type 11
Pontocerebellar Hypoplasia, Type 1d Pontocerebellar Hypoplasia, Type 12
Pontocerebellar Hypoplasia, Type 13 Pontocerebellar Hypoplasia Type 1

Diseases related to Pontocerebellar Hypoplasia Type 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 60)
# Related Disease Score Top Affiliating Genes
1 pontocerebellar hypoplasia, type 1a 31.9 VRK1 CHMP1A
2 pontocerebellar hypoplasia, type 5 31.4 VRK1 TSEN54
3 pontocerebellar hypoplasia, type 6 30.9 TSEN54 RARS2
4 pontocerebellar hypoplasia, type 1b 29.9 VRK1 EXOSC9 EXOSC8 EXOSC3
5 polyhydramnios 29.8 VRK1 TSEN54
6 anterior horn cell disease 29.7 VRK1 TSEN54 RARS2 EXOSC3
7 pontocerebellar hypoplasia 28.9 VRK1 TSEN54 RARS2 EXOSC9 EXOSC8 EXOSC3
8 pontocerebellar hypoplasia, type 4 10.9
9 pontocerebellar hypoplasia, type 2a 10.9
10 pontocerebellar hypoplasia, type 3 10.9
11 pontocerebellar hypoplasia, type 2b 10.9
12 pontocerebellar hypoplasia, type 2c 10.9
13 pontocerebellar hypoplasia, type 8 10.9
14 pontocerebellar hypoplasia, type 7 10.9
15 pontocerebellar hypoplasia, type 10 10.9
16 pontocerebellar hypoplasia, type 9 10.9
17 pontocerebellar hypoplasia, type 11 10.9
18 spinal muscular atrophy 10.5
19 muscular atrophy 10.5
20 hypotonia 10.5
21 exosc3 pontocerebellar hypoplasia 10.4
22 spinal muscular atrophy, type i 10.3
23 spinal muscular atrophy, x-linked 2 10.3
24 olivopontocerebellar atrophy 10.3
25 ataxia and polyneuropathy, adult-onset 10.3
26 microcephaly 10.3
27 congenital disorders of n-linked glycosylation and multiple pathway 10.2
28 non-syndromic pontocerebellar hypoplasia 10.1 TSEN54 EXOSC3
29 spinocerebellar ataxia 1 10.1
30 3-methylglutaconic aciduria, type iii 10.1
31 retinitis pigmentosa 10.1
32 neuropathy, ataxia, and retinitis pigmentosa 10.1
33 bainbridge-ropers syndrome 10.1
34 neuroretinitis 10.1
35 respiratory failure 10.1
36 autosomal dominant cerebellar ataxia 10.1
37 cerebral palsy 10.1
38 motor neuron disease 10.1
39 retinitis 10.1
40 dystonia 10.1
41 mitochondrial metabolism disease 10.1
42 axonal neuropathy 10.1
43 pathologic nystagmus 10.1
44 asxl3-related disorder 10.1
45 congenital contractures 10.1
46 dysphagia 10.1
47 hypertonia 10.1
48 spasticity 10.1
49 congenital amyoplasia 10.1
50 cavitary optic disc anomalies 9.9

Graphical network of the top 20 diseases related to Pontocerebellar Hypoplasia Type 1:



Diseases related to Pontocerebellar Hypoplasia Type 1

Symptoms & Phenotypes for Pontocerebellar Hypoplasia Type 1

UMLS symptoms related to Pontocerebellar Hypoplasia Type 1:


ataxia, muscle weakness, muscular fasciculation, weakness

Drugs & Therapeutics for Pontocerebellar Hypoplasia Type 1

Search Clinical Trials , NIH Clinical Center for Pontocerebellar Hypoplasia Type 1

Genetic Tests for Pontocerebellar Hypoplasia Type 1

Genetic tests related to Pontocerebellar Hypoplasia Type 1:

# Genetic test Affiliating Genes
1 Pontocerebellar Hypoplasia Type 1 29

Anatomical Context for Pontocerebellar Hypoplasia Type 1

MalaCards organs/tissues related to Pontocerebellar Hypoplasia Type 1:

40
Brain, Cerebellum, Pons, Spinal Cord

Publications for Pontocerebellar Hypoplasia Type 1

Articles related to Pontocerebellar Hypoplasia Type 1:

(show all 30)
# Title Authors PMID Year
1
Novel EXOSC3 mutation causes complicated hereditary spastic paraplegia. 6 61
25149867 2014
2
Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma. 61 6
23883322 2013
3
Exome sequencing in a family with intellectual disability, early onset spasticity, and cerebellar atrophy detects a novel mutation in EXOSC3. 61 6
23975261 2013
4
Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. 61 6
22544365 2012
5
Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. 6 61
19646678 2009
6
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia. 6
24989451 2014
7
Deep sequencing reveals 50 novel genes for recessive cognitive disorders. 6
21937992 2011
8
Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia. 61
33463720 2021
9
Expanded PCH1D phenotype linked to EXOSC9 mutation. 61
30690203 2020
10
Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy. 61
30976113 2019
11
De novo variant in KIF26B is associated with pontocerebellar hypoplasia with infantile spinal muscular atrophy. 61
30151950 2018
12
Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature. 61
29656927 2018
13
Whole exome sequencing diagnoses the first fetal case of Bainbridge-Ropers syndrome presenting as pontocerebellar hypoplasia type 1. 61
29316359 2018
14
EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations. 61
24524299 2014
15
Pontocerebellar hypoplasia type 1 with a milder phenotype in a two-year-old girl. 61
24891912 2014
16
Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations. 61
23284067 2013
17
TSEN54 mutation in a child with pontocerebellar hypoplasia type 1. 61
21468723 2011
18
Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. 61
20952379 2011
19
Autopsy case of later-onset pontocerebellar hypoplasia type 1: pontine atrophy and pyramidal tract involvement. 61
20558670 2010
20
Delayed gyration with pontocerebellar hypoplasia type 1. 61
19243903 2010
21
A mild variant of pontocerebellar hypoplasia type 1 in a 12-year-old Indian boy. 61
19302945 2009
22
Macrocephaly in association with pontocerebellar hypoplasia type 1: a paradox. 61
19359782 2009
23
Pontocerebellar hypoplasia type 1. 61
18805371 2008
24
Infantile onset progressive cerebellar atrophy and anterior horn cell degeneration--a late onset variant of PCH-1? 61
17681808 2008
25
[Pontocerebellar hypoplasia type 1: a case report]. 61
17342678 2007
26
Pontocerebellar hypoplasia type 1: new leads for an earlier diagnosis. 61
12731647 2003
27
Extended phenotype of pontocerebellar hypoplasia with infantile spinal muscular atrophy. 61
12548734 2003
28
Analysis and classification of cerebellar malformations. 61
12169461 2002
29
Pontocerebellar hypoplasia type 2 (PCH2): report of two siblings. 61
10814903 2000
30
Pontocerebellar hypoplasia associated with respiratory-chain defects. 61
10401692 1999

Variations for Pontocerebellar Hypoplasia Type 1

ClinVar genetic disease variations for Pontocerebellar Hypoplasia Type 1:

6 (show top 50) (show all 206)
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 EXOSC3 NM_016042.4(EXOSC3):c.415G>C (p.Ala139Pro) SNV Pathogenic 31689 rs387907195 9:37783970-37783970 9:37783973-37783973
2 EXOSC3 NM_016042.4(EXOSC3):c.294_303del (p.Val99fs) Deletion Pathogenic 31690 rs672601331 9:37784739-37784748 9:37784742-37784751
3 EXOSC3 NM_016042.4(EXOSC3):c.712T>C (p.Trp238Arg) SNV Pathogenic 31692 rs672601332 9:37780792-37780792 9:37780795-37780795
4 EXOSC3 NM_016042.4(EXOSC3):c.571G>T (p.Gly191Cys) SNV Pathogenic 183048 rs730882145 9:37782038-37782038 9:37782041-37782041
5 EXOSC3 NM_016042.4(EXOSC3):c.112del (p.Glu38fs) Deletion Pathogenic 129023 rs587780333 9:37784930-37784930 9:37784933-37784933
6 EXOSC3 NM_016042.4(EXOSC3):c.155del (p.Pro52fs) Deletion Pathogenic 280004 rs886041316 9:37784887-37784887 9:37784890-37784890
7 EXOSC8 NM_181503.3(EXOSC8):c.815G>C (p.Ser272Thr) SNV Pathogenic 157608 rs36027220 13:37583420-37583420 13:37009283-37009283
8 EXOSC8 NM_181503.3(EXOSC8):c.5C>T (p.Ala2Val) SNV Pathogenic 157609 rs606231285 13:37574947-37574947 13:37000810-37000810
9 VRK1 NM_003384.3(VRK1):c.706G>A (p.Val236Met) SNV Pathogenic 218924 rs771364038 14:97321690-97321690 14:96855353-96855353
10 VRK1 NM_003384.3(VRK1):c.266G>A (p.Arg89Gln) SNV Pathogenic 197213 rs773138218 14:97312481-97312481 14:96846144-96846144
11 VRK1 NM_003384.3(VRK1):c.879_882AAAC[1] (p.Lys295fs) Microsatellite Pathogenic 464942 rs779282547 14:97322913-97322916 14:96856576-96856579
12 VRK1 NM_003384.3(VRK1):c.397C>T (p.Arg133Cys) SNV Pathogenic 30243 rs387906830 14:97319190-97319190 14:96852853-96852853
13 VRK1 NM_003384.3(VRK1):c.265C>T (p.Arg89Ter) SNV Pathogenic 533537 rs772263867 14:97312480-97312480 14:96846143-96846143
14 VRK1 NM_003384.3(VRK1):c.6del (p.Arg3fs) Deletion Pathogenic 533538 rs780789145 14:97299814-97299814 14:96833477-96833477
15 VRK1 NM_003384.3(VRK1):c.266G>A (p.Arg89Gln) SNV Pathogenic 197213 rs773138218 14:97312481-97312481 14:96846144-96846144
16 VRK1 NC_000014.9:g.(?_96846075)_(96847364_?)del Deletion Pathogenic 584083 14:97312412-97313701 14:96846075-96847364
17 VRK1 NC_000014.9:g.(?_96856120)_(96860745_?)del Deletion Pathogenic 643149 14:97322457-97327082 14:96856120-96860745
18 VRK1 NM_003384.3(VRK1):c.362_365del (p.Lys121fs) Deletion Pathogenic 644618 rs772146380 14:97313668-97313671 14:96847331-96847334
19 VRK1 NM_003384.3(VRK1):c.1066A>T (p.Lys356Ter) SNV Pathogenic 654056 rs1223645705 14:97327070-97327070 14:96860733-96860733
20 VRK1 NM_003384.3(VRK1):c.976C>T (p.Gln326Ter) SNV Pathogenic 619220 rs1566713184 14:97326980-97326980 14:96860643-96860643
21 VRK1 NC_000014.9:g.(?_96810669)_(96860745_?)del Deletion Pathogenic 657389 14:97277006-97327082 14:96810669-96860745
22 VRK1 NC_000014.9:g.(?_96846085)_(96847354_?)del Deletion Pathogenic 832438 14:97312422-97313691
23 VRK1 NM_003384.3(VRK1):c.660T>A (p.Cys220Ter) SNV Pathogenic 846403 14:97321644-97321644 14:96855307-96855307
24 VRK1 NM_003384.3(VRK1):c.9del (p.Arg3_Val4insTer) Deletion Pathogenic 847284 14:97299817-97299817 14:96833480-96833480
25 VRK1 NM_003384.3(VRK1):c.156T>A (p.Tyr52Ter) SNV Pathogenic 861842 14:97299964-97299964 14:96833627-96833627
26 EXOSC3 NM_016042.4(EXOSC3):c.92G>C (p.Gly31Ala) SNV Pathogenic 31691 rs387907196 9:37784950-37784950 9:37784953-37784953
27 VRK1 NM_003384.3(VRK1):c.1072C>T (p.Arg358Ter) SNV Pathogenic 7497 rs137853063 14:97342370-97342370 14:96876033-96876033
28 VRK1 NM_003384.3(VRK1):c.961C>T (p.Arg321Cys) SNV Pathogenic 209205 rs772731615 14:97326965-97326965 14:96860628-96860628
29 VRK1 NM_003384.3(VRK1):c.1072C>T (p.Arg358Ter) SNV Pathogenic 7497 rs137853063 14:97342370-97342370 14:96876033-96876033
30 EXOSC3 NM_016042.4(EXOSC3):c.395A>C (p.Asp132Ala) SNV Pathogenic/Likely pathogenic 31688 rs141138948 9:37783990-37783990 9:37783993-37783993
31 VRK1 NM_003384.3(VRK1):c.1132_1133insT (p.Thr378fs) Insertion Likely pathogenic 971948 14:97342430-97342431 14:96876093-96876094
32 EXOSC3 NM_016042.4(EXOSC3):c.238G>T (p.Val80Phe) SNV Likely pathogenic 129024 rs374550999 9:37784804-37784804 9:37784807-37784807
33 VRK1 NM_003384.3(VRK1):c.402_890-895del Deletion Likely pathogenic 842535 14:97319190-97325994 14:96852853-96859657
34 VRK1 NM_003384.3(VRK1):c.889+1G>A SNV Likely pathogenic 941929 14:97322924-97322924 14:96856587-96856587
35 VRK1 NM_003384.3(VRK1):c.889+1G>T SNV Likely pathogenic 945901 14:97322924-97322924 14:96856587-96856587
36 VRK1 NM_003384.3(VRK1):c.976C>T (p.Gln326Ter) SNV Likely pathogenic 619220 rs1566713184 14:97326980-97326980 14:96860643-96860643
37 VRK1 NM_003384.2(VRK1):c.318_889+1945del Deletion Likely pathogenic 567048 14:97313625-97324868 14:96847288-96858531
38 VRK1 NM_003384.3(VRK1):c.356A>G (p.His119Arg) SNV Likely pathogenic 209204 rs371295780 14:97313663-97313663 14:96847326-96847326
39 CHMP1A NM_002768.5(CHMP1A):c.346G>A (p.Glu116Lys) SNV Likely pathogenic 522948 rs1064794609 16:89713646-89713646 16:89647238-89647238
40 VRK1 NM_003384.3(VRK1):c.156_160+3del Deletion Likely pathogenic 624564 rs1566696845 14:97299962-97299969 14:96833625-96833632
41 EXOSC3 NM_016042.4(EXOSC3):c.572G>A (p.Gly191Asp) SNV Likely pathogenic 210965 rs797045567 9:37782037-37782037 9:37782040-37782040
42 EXOSC3 NM_016042.4(EXOSC3):c.166A>C (p.Asn56His) SNV Conflicting interpretations of pathogenicity 366878 rs148348866 9:37784876-37784876 9:37784879-37784879
43 EXOSC3 NM_016042.4(EXOSC3):c.53G>C (p.Arg18Pro) SNV Conflicting interpretations of pathogenicity 746975 rs145677716 9:37784989-37784989 9:37784992-37784992
44 EXOSC3 NM_016042.4(EXOSC3):c.52C>T (p.Arg18Cys) SNV Conflicting interpretations of pathogenicity 746976 rs147135294 9:37784990-37784990 9:37784993-37784993
45 VRK1 NM_003384.3(VRK1):c.961C>T (p.Arg321Cys) SNV Conflicting interpretations of pathogenicity 209205 rs772731615 14:97326965-97326965 14:96860628-96860628
46 VRK1 NM_003384.3(VRK1):c.858G>T (p.Met286Ile) SNV Uncertain significance 130730 rs139476915 14:97322892-97322892 14:96856555-96856555
47 VRK1 NM_003384.3(VRK1):c.882C>G (p.Asn294Lys) SNV Uncertain significance 286548 rs541660707 14:97322916-97322916 14:96856579-96856579
48 VRK1 NM_003384.3(VRK1):c.901A>G (p.Lys301Glu) SNV Uncertain significance 315123 rs149661915 14:97326905-97326905 14:96860568-96860568
49 VRK1 NM_003384.3(VRK1):c.1021C>T (p.Leu341Phe) SNV Uncertain significance 451762 rs139734064 14:97327025-97327025 14:96860688-96860688
50 VRK1 NM_003384.3(VRK1):c.858G>T (p.Met286Ile) SNV Uncertain significance 130730 rs139476915 14:97322892-97322892 14:96856555-96856555

Expression for Pontocerebellar Hypoplasia Type 1

Search GEO for disease gene expression data for Pontocerebellar Hypoplasia Type 1.

Pathways for Pontocerebellar Hypoplasia Type 1

GO Terms for Pontocerebellar Hypoplasia Type 1

Cellular components related to Pontocerebellar Hypoplasia Type 1 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleus GO:0005634 9.87 VRK1 TSEN54 EXOSC9 EXOSC8 EXOSC3 CHMP1A
2 nucleolus GO:0005730 9.73 VRK1 TSEN54 EXOSC9 EXOSC8 EXOSC3 AGTPBP1
3 exosome (RNase complex) GO:0000178 9.33 EXOSC9 EXOSC8 EXOSC3
4 nuclear exosome (RNase complex) GO:0000176 9.13 EXOSC9 EXOSC8 EXOSC3
5 cytoplasmic exosome (RNase complex) GO:0000177 8.8 EXOSC9 EXOSC8 EXOSC3

Biological processes related to Pontocerebellar Hypoplasia Type 1 according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 rRNA processing GO:0006364 9.7 EXOSC9 EXOSC8 EXOSC3
2 regulation of mRNA stability GO:0043488 9.67 EXOSC9 EXOSC8 EXOSC3
3 exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay GO:0043928 9.54 EXOSC9 EXOSC8 EXOSC3
4 rRNA catabolic process GO:0016075 9.51 EXOSC9 EXOSC8
5 nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' GO:0034427 9.5 EXOSC9 EXOSC8 EXOSC3
6 nuclear mRNA surveillance GO:0071028 9.48 EXOSC9 EXOSC8
7 nuclear polyadenylation-dependent mRNA catabolic process GO:0071042 9.46 EXOSC9 EXOSC8
8 U5 snRNA 3'-end processing GO:0034476 9.43 EXOSC9 EXOSC8
9 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) GO:0000467 9.43 EXOSC9 EXOSC8 EXOSC3
10 U1 snRNA 3'-end processing GO:0034473 9.4 EXOSC9 EXOSC8
11 U4 snRNA 3'-end processing GO:0034475 9.33 EXOSC9 EXOSC8 EXOSC3
12 nuclear polyadenylation-dependent tRNA catabolic process GO:0071038 9.13 EXOSC9 EXOSC8 EXOSC3
13 nuclear polyadenylation-dependent rRNA catabolic process GO:0071035 8.8 EXOSC9 EXOSC8 EXOSC3

Molecular functions related to Pontocerebellar Hypoplasia Type 1 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 3'-5'-exoribonuclease activity GO:0000175 9.16 EXOSC9 EXOSC3
2 mRNA 3'-UTR AU-rich region binding GO:0035925 8.96 EXOSC9 EXOSC8
3 exoribonuclease activity GO:0004532 8.8 EXOSC9 EXOSC8 EXOSC3

Sources for Pontocerebellar Hypoplasia Type 1

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....